Shalini Kulasingam, Ph.D., MPH
Associate Professor, Division of Epidemiology and Community Health
School of Public Health, University of Minnesota, Twin Cities

Locations:

• Geffen Auditorium Hall (Live)
• Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

• Integrate the use of a risk based approach to incorporating new screening tests for cervical cancer screening
• Provide a justification used by the ACS-ASCCP-ACP for choosing a 5 year interval for screening with HPV tests
• Describe how HPV vaccination may impact cervical cancer screening and affect the balance of harms and benefits as more women are vaccinated

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.